Iede K, Yamada T, Koh M, Ueda M, et al. Baseline Factors Predictive of the Receipt of Second-Line Chemotherapy After Nab-Paclitaxel Plus Gemcitabine for Patients With Advanced Pancreatic Cancer. Pancreas 2022;51:278-281.
PMID: 35584386